Cosmos Holdings, Inc. Enters the Nutraceutical Industry

CHICAGO, Jan. 09, 2018 -- Cosmos Holdings, Inc. (OTCQB:COSM), through its wholly owned subsidiary Sky Pharm S.A., announces its agreement with Doc Pharma S.A.  The agreement with Doc Pharma S.A. (cGMP) outlines the development and contract manufacturing of Cosmos Holdings' complete line of food supplements.

Doc Pharma S.A. is a Greece-based (cGMP) licensed contract manufacturer with production facilities in Athens, Greece.  Under the agreement, Doc Pharma S.A. will research, develop formulation, design product packaging, complete product registration, and provide market-ready products.  Production is expected to begin in the first quarter of 2018 and the first sales are expected to start in the second quarter of 2018.  More information is available at  https://www.docpharma.gr/en/.

Cosmos Holdings CEO Gregory Siokas commented, “This marks the completion of yet another milestone for Cosmos Holdings Inc.  We have aggressively expanded our European network through our pharmaceutical trade division and are looking forward to the utilization of that network to sell our own brand of premium nutraceuticals.”

About Cosmos Holdings, Inc.

Cosmos Holdings Inc. is a pharmaceutical wholesaler with offices and warehouses in Thessaloniki, Greece and in Harlow, UK.  The Company has a trans-European network of over 110 clients and vendors which expands to 16 countries including: Germany, United Kingdom, Ireland, United Arab Emirates, Denmark, Italy, France, Singapore, Spain, Lebanon, Skopje, Jordan, Sweden, Poland, Netherlands, and Greece.  More information is available at www.cosmosholdingsinc.com.

Cosmos Holdings, Inc. takes no responsibility for updating the information contained in this press release following the date hereof to reflect events or circumstances occurring after the date hereof or the occurrence of unanticipated events or for any changes or modifications made to this press release or the information contained herein by any third-parties, including, but not limited to, any wire or internet services.

FORWARD LOOKING STATEMENTS

Except for historical information, this news release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve unknown risks, and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Important factors that might cause such differences are discussed in the Company's filings with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results could differ materially from those anticipated in these forward-looking statements, if new information becomes available in the future.

Steve Carr 
Managing Director 
Dresner Corporate Services 
(312) 780-7211 
[email protected]

Integra Consulting Group LLC 
Jeremy Roe 
Managing Partner 
+1 925 262 8305 
[email protected]